Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 Dec;16(6):725–727. doi: 10.1111/j.1365-2125.1983.tb02250.x

Acute treatment of hypertensive crisis with nifedipine.

F T Huysmans, H E Sluiter, T A Thien, R A Koene
PMCID: PMC1428348  PMID: 6661359

Abstract

Ten patients with a hypertensive crisis and a decreased renal function were treated with 10 (n = 7) or 20 (n = 3) mg nifedipine sublingually. Blood pressure was reduced in 60 min from 211 +/- 4/134 +/- 5 to 172 +/- 6/107 +/- 6 mm Hg. The decrease of blood pressure was accompanied by a rise in heart rate from 83 +/- 6 to 98 +/- 5 beats/min. In all seven patients with an encephalopathy signs of this complication were reduced. No serious side-effects were observed.

Full text

PDF
725

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayley S., Dobbs R. J., Robinson B. F. Nifedipine in the treatment of hypertension: report of a double-blind controlled trial. Br J Clin Pharmacol. 1982 Oct;14(4):509–512. doi: 10.1111/j.1365-2125.1982.tb02021.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bertel O., Conen D., Radü E. W., Müller J., Lang C., Dubach U. C. Nifedipine in hypertensive emergencies. Br Med J (Clin Res Ed) 1983 Jan 1;286(6358):19–21. doi: 10.1136/bmj.286.6358.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Low R. I., Takeda P., Mason D. T., DeMaria A. N. The effects of calcium channel blocking agents on cardiovascular function. Am J Cardiol. 1982 Feb 18;49(3):547–553. doi: 10.1016/s0002-9149(82)80010-6. [DOI] [PubMed] [Google Scholar]
  4. Millard R. W., Lathrop D. A., Grupp G., Ashraf M., Grupp I. L., Schwartz A. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms. Am J Cardiol. 1982 Feb 18;49(3):499–506. doi: 10.1016/s0002-9149(82)80002-7. [DOI] [PubMed] [Google Scholar]
  5. Murakami M., Murakami E., Takekoshi N., Tsuchiya M., Kin T. Antihypertensive effect of (4-2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonic acid dimethylester (Nifedipine, Bay-a 1040), a new coronary dilator. Jpn Heart J. 1972 Mar;13(2):128–135. doi: 10.1536/ihj.13.128. [DOI] [PubMed] [Google Scholar]
  6. Romhilt D. W., Estes E. H., Jr A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 1968 Jun;75(6):752–758. doi: 10.1016/0002-8703(68)90035-5. [DOI] [PubMed] [Google Scholar]
  7. Yoshimura M., Takashina R., Shikuma R., Takahashi H., Takeda K., Ashizawa H., Ochi Y., Ijichi H. Antihypertensive effect of nifedipine and its relationship to severity of hypertension. Arzneimittelforschung. 1983;33(2):254–257. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES